Vitiligo | Incyte | INCB18424-306 (TRuE-V1)
Pharmaceutical Company/Sponsor:
Incyte
Code:
INCB18424-306 (TRuE-V1)
Title:
Topical Ruxolitinib Evaluation in Vitiligo Study 1 (TRuE-V1): A Phase 3, Double-Blind, Randomized, Vehicle-Controlled, Efficacy and Safety Study of Ruxolitinib Cream Followed by an Extension Period in Participants With Vitiligo
Type:
Interventional
Phase:
3
Condition/Disease:
Vitiligo
Intervention(s)/Treatment(s):
Drug: Ruxolitinib cream
Drug: Vehicle
Status:
Active, Not Recruiting
Link for Additional Information:
